SCHEMBL17744007

SCHEMBL17744007

CCCCCCCCCCC(O)CCCCCCCC=CC[C@@H](CCCCCC)OC(=O)CCC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 2/20 0.58
FFAR1 O14842 1/20 0.58
FAAH O00519 3/20 0.51
ALDH1A1 P00352 1/20 0.51
MAPT P10636 1/20 0.51
HPGD P15428 1/20 0.51
CNR1 P21554 1/20 0.51
CNR2 P34972 1/20 0.51
PRKCA P17252 2/20 0.51
PRKCE Q02156 1/20 0.51
PRKCQ Q04759 1/20 0.51
PRKCD Q05655 1/20 0.51
SLC6A5 Q9Y345 1/20 0.47
DGKA P23743 1/20 0.47
LPAR1 Q92633 1/20 0.46
NFKB1 P19838 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46
DAGLA Q9Y4D2 1/20 0.45
S1PR1 P21453 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17744005 1.00 FFAR4 (0.58) FFAR4FFAR1FAAHALDH1A1MAPT
SCHEMBL17744006 1.00 FFAR4 (0.58) FFAR4FFAR1FAAHALDH1A1MAPT
SCHEMBL22274216 1.00 FFAR4 (0.58) FFAR4FFAR1FAAHALDH1A1MAPT
SCHEMBL17744101 0.95 FFAR1 (0.61) FFAR4FFAR1FAAHALDH1A1MAPT
SCHEMBL17744104 0.95 FFAR1 (0.61) FFAR4FFAR1FAAHALDH1A1MAPT
SCHEMBL22274247 0.95 FFAR1 (0.61) FFAR4FFAR1FAAHALDH1A1MAPT
SCHEMBL17744098 0.95 FFAR1 (0.61) FFAR4FFAR1FAAHALDH1A1MAPT
SCHEMBL22550050 0.91 FFAR1 (0.67) FFAR4FFAR1FAAHALDH1A1MAPT
SCHEMBL3874930 0.90 FFAR1 (0.70) FFAR4FFAR1FAAHMAPTPRKCA
SCHEMBL27402994 0.90 FFAR1 (0.56) FFAR4FFAR1FAAHALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10731159-B2 Cationic lipid DAIICHI SANKYO COMPANY, LIMITED (JP) 2020-08-04 US disclosed
US-20200080086-A1 CATIONIC LIPID DAIICHI SANKYO COMPANY, LIMITED (JP) 2020-03-12 US disclosed
EP-3020701-B1 NOVEL LIPID DAIICHI SANKYO CO LTD (JP) 2018-09-26 EP disclosed
US-20180051285-A1 CATIONIC LIPID DAIICHI SANKYO COMPANY, LIMITED (JP) 2018-02-22 US disclosed
US-9803199-B2 Cationic lipid DAIICHI SANKYO COMPANY, LIMITED (JP) 2017-10-31 US disclosed
US-20160257951-A1 NOVEL LIPID DAIICHI SANKYO COMPANY, LIMITED (JP) 2016-09-08 US disclosed
EP-3020701-A1 NOVEL LIPID DAIICHI SANKYO COMPANY, LIMITED (JP) 2016-05-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160257951-A1 NOVEL LIPID NPC1L1, CETP, LIPC FFAR4 195/4885FFAR1 183/4885FAAH 513/4885
US-20180051285-A1 CATIONIC LIPID CETP, NPC1L1, LIPA FFAR4 175/4885FFAR1 161/4885FAAH 748/4885
US-20200080086-A1 CATIONIC LIPID CETP, NPC1L1, LIPA FFAR4 175/4885FFAR1 161/4885FAAH 748/4885
US-10731159-B2 Cationic lipid CETP, NPC1L1, LIPA FFAR4 175/4885FFAR1 161/4885FAAH 748/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.